COMP <GO>
MRK vs PM // ALTMAN Z-SCORE & DEBT/EQUITY
Merck & Company Inc. (NYSE) VS. Philip Morris International Inc (NYSE) • 15-METRIC TALLY: MRK 7
— PM 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
balance-sheet
5.19
LAST: $208.50 (+2.89%) • MKT CAP: $324.98B
balance-sheet
4.52
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MRK VS. PM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MRK | PM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.80% | 67.10% | +7.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.70% | 45.30% | -24.60 | PM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.3x | 21.7x | -6.40 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.42% | 3.28% | +0.14 | MRK | /fcf-yield <GO> |
| Operating Margin | 34.30% | 36.60% | -2.30 | PM | /operating-margins <GO> |
| Net Profit Margin | 28.10% | 27.90% | +0.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 1.30% | 7.30% | -6.00 | PM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.26% | 2.65% | -0.39 | PM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 5.19 | 4.52 | +0.67 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | PM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 63.9 | -12.20 | PM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 0.93 | -0.01 | PM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.4x | 26.6x | -8.20 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $361.02B | $324.98B | $36.04B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MRK REV | PM REV | MRK GROSS % | PM GROSS % | MRK FCF | PM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $65.01B | $40.65B | 74.8% | 67.1% | $12.36B | $10.66B |
| FY 2024 | $64.17B | $37.88B | 76.3% | 64.8% | $18.10B | $10.77B |
| FY 2023 | $60.12B | $35.17B | — | — | $10.30B | $7.62B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MRK // BETA 0.92
PM // BETA 0.93